As of 2025-11-15, the EV/EBITDA ratio of Fortress Biotech Inc (FBIO) is -0.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FBIO's latest enterprise value is 57.34 mil USD. FBIO's TTM EBITDA according to its financial statements is -98.90 mil USD. Dividing these 2 quantities gives us the above FBIO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 15.8x | 14.2x |
| Forward P/E multiples | 22.4x - 43.4x | 32.9x |
| Fair Price | (73.77) - (51.83) | (77.59) |
| Upside | -2915.7% - -2078.2% | -3061.6% |
| Date | EV/EBITDA |
| 2025-11-13 | -0.54 |
| 2025-11-12 | -0.58 |
| 2025-11-11 | -0.60 |
| 2025-11-10 | -0.57 |
| 2025-11-07 | -0.58 |
| 2025-11-06 | -0.55 |
| 2025-11-05 | -0.54 |
| 2025-11-04 | -0.53 |
| 2025-11-03 | -0.53 |
| 2025-10-31 | -0.56 |
| 2025-10-30 | -0.56 |
| 2025-10-29 | -0.55 |
| 2025-10-28 | -0.56 |
| 2025-10-27 | -0.56 |
| 2025-10-24 | -0.55 |
| 2025-10-23 | -0.55 |
| 2025-10-22 | -0.56 |
| 2025-10-21 | -0.62 |
| 2025-10-20 | -0.62 |
| 2025-10-17 | -0.60 |
| 2025-10-16 | -0.62 |
| 2025-10-15 | -0.64 |
| 2025-10-14 | -0.61 |
| 2025-10-13 | -0.63 |
| 2025-10-10 | -0.61 |
| 2025-10-09 | -0.63 |
| 2025-10-08 | -0.67 |
| 2025-10-07 | -0.71 |
| 2025-10-06 | -0.73 |
| 2025-10-03 | -0.62 |
| 2025-10-02 | -0.63 |
| 2025-10-01 | -0.56 |
| 2025-09-30 | -0.90 |
| 2025-09-29 | -0.96 |
| 2025-09-26 | -0.97 |
| 2025-09-25 | -0.92 |
| 2025-09-24 | -0.90 |
| 2025-09-23 | -0.89 |
| 2025-09-22 | -0.99 |
| 2025-09-19 | -0.90 |
| 2025-09-18 | -0.86 |
| 2025-09-17 | -0.83 |
| 2025-09-16 | -0.82 |
| 2025-09-15 | -0.86 |
| 2025-09-12 | -0.96 |
| 2025-09-11 | -0.94 |
| 2025-09-10 | -0.95 |
| 2025-09-09 | -0.87 |
| 2025-09-08 | -0.87 |
| 2025-09-05 | -0.91 |